Beam Therapeutics (BEAM) Change in Account Payables (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Change in Account Payables data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 41.58% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 3.43% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 234.26% from the prior year.
• Change in Account Payables for Q1 2026 stood at $2.2 million, up from $1.2 million in the prior quarter.
• Over the last five years, Change in Account Payables for BEAM reached as high as $3.8 million in Q1 2025 and fell as low as -$3.0 million in Q3 2023.
• Historically, Change in Account Payables has averaged $285764.7 across 5 years, with a median of $102000.0 in 2022.
• Across the five-year window, Change in Account Payables tumbled 2584.31% in 2023 and surged 656.28% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at $2.9 million in 2022, then tumbled by 160.97% to -$1.8 million in 2023, then surged by 68.89% to -$550000.0 in 2024, then surged by 317.09% to $1.2 million in 2025, then jumped by 85.59% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $2.2 million in Q1 2026, $1.2 million in Q4 2025, and -$1.6 million in Q3 2025.